Edap Tms (NASDAQ:EDAP) Share Price Passes Above 200 Day Moving Average of $6.29

Edap Tms S.A. (NASDAQ:EDAP) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.29 and traded as high as $7.34. Edap Tms shares last traded at $7.28, with a volume of 63,516 shares.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on EDAP shares. HC Wainwright raised their target price on shares of Edap Tms from $16.00 to $19.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. StockNews.com lowered shares of Edap Tms from a “hold” rating to a “sell” rating in a report on Friday, April 19th.

Edap Tms Stock Down 1.6 %

The stock has a market cap of $270.09 million, a price-to-earnings ratio of -11.56 and a beta of 0.74. The company has a current ratio of 2.84, a quick ratio of 2.30 and a debt-to-equity ratio of 0.04. The stock’s 50-day moving average price is $7.22 and its 200-day moving average price is $6.29.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.13). The company had revenue of $21.27 million during the quarter, compared to the consensus estimate of $21.30 million. Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. On average, sell-side analysts expect that Edap Tms S.A. will post -0.31 earnings per share for the current year.

Institutional Trading of Edap Tms

Several hedge funds have recently modified their holdings of EDAP. Miracle Mile Advisors LLC bought a new stake in Edap Tms during the 1st quarter valued at $136,000. Rock Springs Capital Management LP boosted its holdings in shares of Edap Tms by 14.6% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock worth $9,547,000 after buying an additional 173,700 shares during the last quarter. Milestone Investment Advisors LLC purchased a new position in shares of Edap Tms in the 3rd quarter worth about $39,000. Finally, Summit Trail Advisors LLC purchased a new position in shares of Edap Tms in the 3rd quarter worth about $77,000. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.